# Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems

> **NCT03961776** · — · RECRUITING · sponsor: **Institut Paoli-Calmettes** · enrollment: 39 (estimated)

## Conditions studied

- Rectal Adenocarcinoma

## Interventions

- **DEVICE:** MRI-guided radiotherapy by on-board DWI sequences

## Key facts

- **NCT ID:** NCT03961776
- **Lead sponsor:** Institut Paoli-Calmettes
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2020-06-08
- **Primary completion:** 2022-05
- **Final completion:** 2027-05
- **Target enrollment:** 39 (ESTIMATED)
- **Last updated:** 2021-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03961776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03961776, "Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03961776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*